— Know what they know.
Not Investment Advice

GELS NASDAQ

Gelteq Limited Ordinary Shares
1W: -4.5% 1M: -25.5% 3M: -12.8% YTD: -37.8% 1Y: -59.6%
$0.52
-0.02 (-3.96%)
 
Weekly Expected Move ±20.8%
$0 $0 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · $4.8M mcap · 4M float · 115.02% daily turnover · Short 35% of daily vol

Income Trends

Revenue
$166K +0.0% ▲
Gross Profit
$166K +0.0% ▲
Operating Income
-$5M -86.5% ▼
Net Income
-$7M -87.4% ▼
EPS (Diluted)
$0.00 +0.0% ▲
EBITDA
-$4M -101.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$148K$80K$0$166K
YoY Growth+0.0%+0.0%-45.9%-100.0%+0.0%
Cost of Revenue$0$95K$49K$0$0
Gross Profit$0$53K$31K$0$166K
Gross Margin—35.7%38.7%—100.0%
R&D Expenses$277K$529K$665K$276K$629K
SG&A Expenses$464K$2M$2M$1M$2M
Operating Expenses$648K$3M$3M$3M$6M
Operating Income-$648K-$3M-$3M-$3M-$5M
Operating Margin—-2164.4%-3885.3%—-3317.7%
Interest Expense$1K$175K$404K$585K$2M
Income Before Tax-$649K-$3M-$4M-$4M-$7M
Tax Expense$0$0$0$0$0
Net Income-$649K-$3M-$4M-$4M-$7M
Net Margin—-2283.4%-4391.4%—-4011.9%
EPS (Diluted)$-0.07$-0.36$-0.37$0.00$0.00
EBITDA-$590K-$2M-$2M-$2M-$4M
Shares Outstanding9M9M9M00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms